Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vivimed Labs is an India-based publicly traded pharmaceutical and specialty chemicals company focused on active pharmaceutical ingredients, finished dosage formulations, branded formulations, and contract development and manufacturing services. The company positions itself as an integrated formulations and CDMO partner with manufacturing facilities in India and formulation development capabilities through its subsidiary Finoso Pharma. Its healthcare activities are centered on commercial generic and branded small-molecule products rather than a disclosed innovative clinical pipeline. Vivimed also has a legacy specialty chemicals business, making it more diversified than a pure-play biotech company. For a biotech analyst, the company is best understood as a commercial-stage pharma manufacturer and services company with API, formulation, R&D, and manufacturing infrastructure rather than a venture-stage therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vivimed Labs.